Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eriochem SafiledCriticalEriochem Sa
Priority to ARP110103435priorityCriticalpatent/AR083066A1/en
Priority to BR112013029758-1Aprioritypatent/BR112013029758A2/en
Priority to US14/117,958prioritypatent/US9029582B2/en
Priority to PCT/ES2012/070267prioritypatent/WO2012160223A1/en
Priority to CA2836831Aprioritypatent/CA2836831C/en
Priority to ES12789794Tprioritypatent/ES2708302T3/en
Priority to EP12789794.0Aprioritypatent/EP2711010B1/en
Priority to MX2013013558Aprioritypatent/MX2013013558A/en
Publication of AR083066A1publicationCriticalpatent/AR083066A1/en
Priority to US14/629,958prioritypatent/US20150202210A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Composición farmacéutica sólida que comprende fulvestrant sólido amorfo. Formulación de dicha composición en combinación con una composición solubilizante. El proceso de elaboración de dicha composición y un kit que la comprende.Solid pharmaceutical composition comprising amorphous solid fulvestrant. Formulation of said composition in combination with a solubilizing composition. The process of making said composition and a kit that includes it.
Thienopyrimidine derivative compounds; Preparation process; pharmaceutical composition that includes them; pharmaceutical combination; use in the treatment of cancers and autoimmune diseases.
Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide.
Cynara extract; pharmaceutical composition that contains it; and its use for the treatment of hyperglycemia, hypercholesterolemia, hypertension and hepatic steatosis.